Thermo Fisher Scientific Inc. (TMO) Stock Analysis
Last updated Oct 27, 2026
Health Check
Last analyzed Oct 23, 2026
- Financial Health 75
- Profitability 60
- Business Quality 65
- Balance Sheet 55
- Cash Flow 60
Why this rating?
Health 64/100 — Good Quality
Entry timing is weak right now. Quality may be fine; the setup is not.
Company overview
Thermo Fisher Scientific Inc. (TMO) is a Diagnostics & Research company in the Healthcare sector. Compound Radar rates Thermo Fisher Scientific Inc. 64/100 (Good Quality) due to solid business quality, steady revenue growth, and manageable leverage.
Investment profile
- Quality Moderate
- Growth Moderate
- Balance Sheet Adequate
- Valuation Fair
Financial highlights
Valuation
- P/E 36.55
- Forward P/E 24.98
- PEG 2.03
- EV/Revenue 6.16
Profitability
- Revenue Growth 9.1%
- Gross Margin 41.2%
- Operating Margin 20.2%
- Net Margin 14.9%
- ROE 13.4%
Financial strength
- Cash $6.06B
- Debt $41.37B
- Net Cash $-35.31B
- Free Cash Flow $6.29B
- Current Ratio 1.81
Similar companies
Peers in Diagnostics & Research, ranked by Financial Health.
Latest quoted price for the name. Helps anchor the setup in today’s market level.
Health Entry- Veracyte, Inc. Diagnostics & Research VCYT$50.28 82 Health 82 / 100
Strong business quality across profitability, growth, balance sheet, and cash flow.
Good Entry Good EntryA usable setup — not as clean as Strong Entry, but timing is not mixed or weak.
- Illumina, Inc. Diagnostics & Research ILMN$271.04 74 Health 74 / 100
Strong business quality across profitability, growth, balance sheet, and cash flow.
Wait WaitEntry timing is weak right now. Quality may be fine; the setup is not.
- CareDx, Inc. Diagnostics & Research CDNA$69.10 73 Health 73 / 100
Strong business quality across profitability, growth, balance sheet, and cash flow.
Wait WaitEntry timing is weak right now. Quality may be fine; the setup is not.
- Qiagen N.V. Diagnostics & Research QGEN$50.37 71 Health 71 / 100
Strong business quality across profitability, growth, balance sheet, and cash flow.
Wait WaitEntry timing is weak right now. Quality may be fine; the setup is not.
- Danaher Corporation Diagnostics & Research DHR$232.00 68 Health 68 / 100
Solid fundamentals with some trade-offs across our health dimensions.
Wait WaitEntry timing is weak right now. Quality may be fine; the setup is not.
- Quest Diagnostics Incorporated Diagnostics & Research DGX$242.56 67 Health 67 / 100
Solid fundamentals with some trade-offs across our health dimensions.
Watch WatchWorth tracking, but timing is mixed — not a clear setup yet.
- Sotera Health Company Diagnostics & Research SHC$18.49 67 Health 67 / 100
Solid fundamentals with some trade-offs across our health dimensions.
Wait WaitEntry timing is weak right now. Quality may be fine; the setup is not.
- Revvity, Inc. Diagnostics & Research RVTY$160.39 66 Health 66 / 100
Solid fundamentals with some trade-offs across our health dimensions.
Wait WaitEntry timing is weak right now. Quality may be fine; the setup is not.
FAQ
How Compound Radar scores and tracks Thermo Fisher Scientific Inc. (TMO).